Literature DB >> 1532419

Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.

A M Verbruggen1, D L Nosco, C G Van Nerom, G M Bormans, P J Adriaens, M J De Roo.   

Abstract

L,L-ethylenedicysteine (L,L-EC) can be labeled efficiently with 99mTc at pH 12 to obtain a highly pure and very stable tracer agent (99mTc-L,L-EC). The biological behavior of 99mTc-L,L-EC was studied in mice and a baboon. In mice, 99mTc-L,L-EC demonstrated a more rapid urinary excretion and less retention in the kidneys, the liver, the intestines, and the blood than did 99mTc-MAG3 at 10 and 60 min p.i. Urinary excretion decreased in probenecid pretreated mice, which indicates active tubular transport. In the baboon, the renograms for 99mTc-MAG3 and 99mTc-L,L-EC were comparable. Plasma-protein binding of 99mTc-L,L-EC was lower than that of 99mTc-MAG3 while its distribution volume and 1-hr plasma clearance were clearly higher. The promising results of the animal experiments suggest that 99mTc-L,L-ethylenedicysteine may be a useful alternative to 99mTc-MAG3 for renal function studies in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532419

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  Preparation and Evaluation of (68)Ga-ECC as a PET Renal Imaging Agent.

Authors:  Alireza Mirzaei; Amir Reza Jalilian; Ayuob Aghanejad; Mohammad Mazidi; Hassan Yousefnia; Gholamali Shabani; Khosro Ardaneh; Parham Geramifar; Davood Beiki
Journal:  Nucl Med Mol Imaging       Date:  2015-02-24

Review 2.  A brief overview of metal complexes as nuclear imaging agents.

Authors:  Douglas S MacPherson; Kimberly Fung; Brendon E Cook; Lynn C Francesconi; Brian M Zeglis
Journal:  Dalton Trans       Date:  2019-10-07       Impact factor: 4.390

3.  Gall Bladder Activity on Technetium99m-Ethylenedicysteine Renogram Masquerading as Ectopic Kidney.

Authors:  Sailaja Aka; J Sai Moulika; Vs Krishna Mohan; R Ramya Priya; Ranadheer Manthri; T C Kalawat
Journal:  Indian J Nucl Med       Date:  2019 Jan-Mar

4.  Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.

Authors:  D J Yang; S Ilgan; T Higuchi; F Zareneyrizi; C S Oh; C W Liu; E E Kim; D A Podoloff
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

5.  The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children.

Authors:  Massoud Majd; Zvi Bar-Sever; Ana Isabel Santos; Diego De Palma
Journal:  J Nucl Med       Date:  2018-10       Impact factor: 10.057

6.  Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells.

Authors:  K A Verbeke; H P Vanbilloen; M J De Roo; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1993-06

7.  First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent.

Authors:  C G Van Nerom; G M Bormans; M J De Roo; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1993-09

8.  Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases.

Authors:  Kazuma Ogawa; Takahiro Mukai; Keiichi Kawai; Norito Takamura; Hirofumi Hanaoka; Kazuyuki Hashimoto; Kazuhiro Shiba; Hirofumi Mori; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-16       Impact factor: 9.236

9.  Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.

Authors:  Grazia Papini; Simone Alidori; Jason S Lewis; David E Reichert; Maura Pellei; Giancarlo Gioia Lobbia; Gráinne B Biddlecombe; Carolyn J Anderson; Carlo Santini
Journal:  Dalton Trans       Date:  2008-11-04       Impact factor: 4.390

10.  Initial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers.

Authors:  Malgorzata Lipowska; Jeffrey Klenc; Russell D Folks; Andrew T Taylor
Journal:  Nucl Med Mol Imaging       Date:  2014-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.